Interleukin-10 production genotype protects against acute persistent rejection after lung transplantation

Journal of Heart and Lung Transplantation

Volumn 23, Issue 5, 2004, Pages 541-546

  Zheng, Hong Xia ^a   Burckart, Gilbert J ^a   McCurry, Kenneth ^b   Webber, Steven ^c   Ristich, Julia ^b   Iacono, Aldo ^c   Dauber, James ^c   McDade, Kevin ^c   Grgurich, Wayne ^c   Zaldonis, Diana ^b   Pillage, Gina ^c   Griffith, Bartley P ^b   Zeevi, Adriana ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT REJECTION; ARTICLE; CYTOKINE PRODUCTION; GENOTYPE; HAPLOTYPE; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTECTION; TRANSBRONCHIAL BIOPSY;

ACUTE DISEASE; FEMALE; GENOTYPE; GRAFT REJECTION; HAPLOTYPES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-6; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2342527023     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(03)00303-6     Document Type: Article

References (33)

1. Awad M.R., Webber S., Boyle G., et al. The effect of cytokine gene polymorphisms on pediatric heart allograft outcome. J Heart Lung Transplant. 20:(6):2001;625-630
2. Bathgate A.J., Pravica V., Perrey C., et al. The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation. 69:(7):2000;1514-1517
3. Aziz T., Hasleton P., Hann A.W., Yonan N., Deiraniya A., Hutchinson I.V. Transforming growth factor beta in relation to cardiac allograft vasculopathy after heart transplantation. J Thoracic Cardiovasc Surg. 119:2000;700-708
4. Hutchinson I.V., Turner D., Sankaran D., Awad M., Pravica V., Sinnott P. Cytokine genotypes in allograft rejection Guidelines for immunosuppression. Transplant Proc. 30:(8):1998;3991-3992
5. Hutchinson I.V., Pravica V., Perrey C., Sinnott P. Cytokine gene polymorphisms and relevance to forms of rejection. Transplant Proc. 31:1999;734-736
6. Hutchinson I.V., Turner D.M., Sankaran D., Awad M.R., Sinnott P.J. Influence of cytokine genotypes on allograft rejection. Transplant Proc. 30:(3):1998;862-863
7. Sankaran D., Asderakis A., Ashraf S., et al. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int. 56:(1):1999;281-288
8. Nadel S., Newport M.J., Booy R., Levin M. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis. 174:(4):1996;878-880
9. Liu Z., Colpaert S., D'Haens G.R., et al. Hyperexpression of CD40 ligand. (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production J Immunol. 163:(7):1999;4049-4057
10. Hobbs K., Negri J., Klinnert M., Rosenwasser L.J., Borish L. Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med. 158:(6):1998;1958-1962
11. Moffatt M.F., Cookson W.O. Tumour necrosis factor haplotypes and asthma. Hum Mol Genet. 6:(4):1997;551-554
12. Lazarus M., Hajeer A.H., Turner D., et al. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol. 24:(12):1997;2314-2317
13. Rood M.J., van Krugten M.V., Zanelli E., et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum. 43:(1):2000;129-134
14. Eskdale J., Wordsworth P., Bowman S., Field M., Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens. 49:(6):1997;635-639
15. Fishman D., Faulds G., Jeffery R., et al. The effect of novel polymorphisms in the interleukin-6. (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis J Clin Invest. 102:(7):1998;1369-1376
16. Mazariegos G.V., Reyes J., Webber S.A., et al. Cytokine gene polymorphisms in children successfully withdrawn from immunosuppression after liver transplantation. Transplantation. 73:(8):2002;1342-1345
17. El-Gamel A., Awad M.R., Hasleton P.S., et al. Transforming growth factor-beta. (TGF-beta1) genotype and lung allograft fibrosis J Heart Lung Transplant. 18:(6):1999;517-523
18. El-Gamel A., Sim E., Hasleton P., et al. Transforming growth factor beta. (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation J Heart Lung Transplant. 18:(9):1999;828-837
19. Kunkel L.M., Smith K.D., Boyer S.H., et al. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci U S A. 74:(3):1977;1245-1249
20. Cox E.D., Hoffmann S.C., DiMercurio B.S., et al. Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation. 72:(4):2001;720-726
21. Turner D., Grant S.C., Yonan N., et al. Cytokine gene polymorphism and heart transplant rejection. Transplantation. 64:(5):1997;776-779
22. Bonfield T.L., Konstan M.W., Burfeind P., Panuska J.R., Hilliard J.B., Berger M. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol. 13:(3):1995;257-261
23. Middleton P.G., Taylor P.R., Jackson G., Proctor S.J., Dickinson A.M. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood. 92:(10):1998;3943-3948
24. Ho A.S., Moore K.W. Interleukin-10 and its receptor. Ther Immunol. 1:(3):1994;173-185
25. Akdis C.A., Blaser K. IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines Two key steps in specific immunotherapy. FASEB J. 13:(6):1999;603-609
26. Azzawi M., Hasleton P.S., Turner D.M., et al. Tumor necrosis factor-alpha gene polymorphism and death due to acute cellular rejection in a subgroup of heart transplant recipients. Hum Immunol. 62:(2):2001;140-142
27. Pelletier R., Pravica V., Perrey C., et al. Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney-pancreas transplantation. Transplantation. 70:(4):2000;674-680
28. Marshall S.E., McLaren A.J., Haldar N.A., Bunce M., Morris P.J., Welsh K.I. The impact of recipient cytokine genotype on acute rejection after renal transplantation. Transplantation. 70:(10):2000;1485-1491
29. Poli F., Boschiero L., Giannoni F., et al. Tumour necrosis factor-alpha gene polymorphism Implications in kidney transplantation. Cytokine. 12:(12):2000;1778-1783
30. Aubert J.D., Dalal B.I., Bai T.R., Roberts C.R., Hayashi S., Hogg J.C. Transforming growth factor beta 1 gene expression in human airways. Thorax. 49:(3):1994;225-232
31. Slavcheva E., Albanis E., Jiao Q., et al. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection. Transplantation. 72:(5):2001;935-940
32. Zheng H.X., Webber S., Zeevi A., et al. The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients. Hum Immunol. 63:2002;765-770
33. Zheng H.X., Webber S., Zeevi A., et al. Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms. Am J Transplant. 3:(4):2003;477-483